The DOI matches its Crossref record; 137 of the 137 references it cites were found in a registry or an index.
Mouse Models of Cancer
Abstract
Genetically engineered mouse models have significantly contributed to our understanding of cancer biology. They have proven to be useful in validating gene functions, identifying novel cancer genes and tumor biomarkers, gaining insight into the molecular and cellular mechanisms underlying tumor initiation and multistage processes of tumorigenesis, and providing better clinical models in which to test novel therapeutic strategies. However, mice still have significant limitations in modeling human cancer, including species-specific differences and inaccurate recapitulation of de novo human tumor development. Future challenges in mouse modeling include the generation of clinically relevant mouse models that recapitulate the molecular, cellular, and genomic events of human cancers and clinical response as well as the development of technologies that allow for efficient in vivo imaging and high-throughput screening in mice.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hypoxia — a key regulatory factor in tumour growth
Harris, A. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc704 · Cited by 5,177
Generalized lacZ expression with the ROSA26 Cre reporter strain
Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 4,859
Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours
Donehower, L. A., Harvey, M., Slagle, B. L., McArthur, M. J., Montgomery, C. A., Butel, J. S., & Bradley, A. (1992) · Nature · doi:10.1038/356215a0 · Cited by 4,649
Germ Line p53 Mutations in a Familial Syndrome of Breast Cancer, Sarcomas, and Other Neoplasms
Malkin, D., Li, F. P., Strong, L. C., Fraumeni, J. F., Nelson, C. E., Kim, D. H., Kassel, J., Gryka, M. A., Bischoff, F. Z., Tainsky, M. A., et al. (1990) · Science · doi:10.1126/science.1978757 · Cited by 3,765
Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse
Hingorani, S. R., Petricoin, E. F., Maitra, A., Rajapakse, V., King, C., Jacobetz, M. A., Ross, S., Conrads, T. P., Veenstra, T. D., Hitt, B. A., et al. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00309-x · Cited by 2,471
Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells
Thomas, K. R., & Capecchi, M. R. (1987) · Cell · doi:10.1016/0092-8674(87)90646-5 · Cited by 2,355
Tumor spectrum analysis in p53-mutant mice
Jacks, T., Remington, L., Williams, B. O., Schmitt, E. M., Halachmi, S., Bronson, R. T., & Weinberg, R. A. (1994) · Current Biology · doi:10.1016/s0960-9822(00)00002-6 · Cited by 2,051
Germline Transmission and Tissue-Specific Expression of Transgenes Delivered by Lentiviral Vectors
Lois, C., Hong, E. J., Pease, S., Brown, E. J., & Baltimore, D. (2002) · Science · doi:10.1126/science.1067081 · Cited by 1,999
Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras
Jackson, E. L., Willis, N., Mercer, K., Bronson, R. T., Crowley, D., Montoya, R., Jacks, T., & Tuveson, D. A. (2001) · Genes & Development · doi:10.1101/gad.943001 · Cited by 1,898
The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice
Adams, J. M., Harris, A. W., Pinkert, C. A., Corcoran, L. M., Alexander, W. S., Cory, S., Palmiter, R. D., & Brinster, R. L. (1985) · Nature · doi:10.1038/318533a0 · Cited by 1,779
Effects of an Rb mutation in the mouse
Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755
Casanovas, O., Hicklin, D. J., Bergers, G., & Hanahan, D. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.09.005 · Cited by 1,621
A Dominant Mutation That Predisposes to Multiple Intestinal Neoplasia in the Mouse
Moser, A. R., Pitot, H. C., & Dove, W. F. (1990) · Science · doi:10.1126/science.2296722 · Cited by 1,591
Multiple Intestinal Neoplasia Caused by a Mutation in the Murine Homolog of the APC Gene
Su, L.-K., Kinzler, K. W., Vogelstein, B., Preisinger, A. C., Moser, A. R., Luongo, C., Gould, K. A., & Dove, W. F. (1992) · Science · doi:10.1126/science.1350108 · Cited by 1,536
Hanahan, D. (1985) · Nature · doi:10.1038/315115a0 · Cited by 1,281
Somatic activation of the K-ras oncogene causes early onset lung cancer in mice
Johnson, L., Mercer, K., Greenbaum, D., Bronson, R. T., Crowley, D., Tuveson, D. A., & Jacks, T. (2001) · Nature · doi:10.1038/35074129 · Cited by 1,179
Friedrich, G., & Soriano, P. (1991) · Genes & Development · doi:10.1101/gad.5.9.1513 · Cited by 1,151
Identification and validation of oncogenes in liver cancer using an integrative oncogenomic approach
Zender, L., Spector, M. S., Xue, W., Flemming, P., Cordon-Cardo, C., Silke, J., Fan, S.-T., Luk, J. M., Wigler, M., Hannon, G. J., et al. (2006) · Cell · doi:10.1016/j.cell.2006.05.030 · Cited by 1,065
Efficient transposition of the piggyBac (PB) transposon in mammalian cells and mice
Ding, S., Wu, X., Li, G., Han, M., Zhuang, Y., & Xu, T. (2005) · Cell · doi:10.1016/j.cell.2005.07.013 · Cited by 1,009
Tumor Induction of VEGF Promoter Activity in Stromal Cells
Fukumura, D., Xavier, R., Sugiura, T., Chen, Y., Park, E.-C., Lu, N., Selig, M., Nielsen, G., Taksir, T., Jain, R. K., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81731-6 · Cited by 996
Effects of Angiogenesis Inhibitors on Multistage Carcinogenesis in Mice
Bergers, G., Javaherian, K., Lo, K.-M., Folkman, J., & Hanahan, D. (1999) · Science · doi:10.1126/science.284.5415.808 · Cited by 988
ErbB2 is essential in the prevention of dilated cardiomyopathy
Crone, S. A., Zhao, Y.-Y., Fan, L., Gu, Y., Minamisawa, S., Liu, Y., Peterson, K. L., Chen, J., Kahn, R., Condorelli, G., et al. (2002) · Nature Medicine · doi:10.1038/nm0502-459 · Cited by 903
Spontaneous mammary adenocarcinomas in transgenic mice that carry and express MTV/myc fusion genes
Stewart, T. A., Pattengale, P. K., & Leder, P. (1984) · Cell · doi:10.1016/0092-8674(84)90257-5 · Cited by 899
Mining the plasma proteome for cancer biomarkers
Hanash, S. M., Pitteri, S. J., & Faca, V. M. (2008) · Nature · doi:10.1038/nature06916 · Cited by 891
Essential role for oncogenic Ras in tumour maintenance
Chin, L., Tam, A., Pomerantz, J., Wong, M., Holash, J., Bardeesy, N., Shen, Q., O'Hagan, R., Pantginis, J., Zhou, H., et al. (1999) · Nature · doi:10.1038/22788 · Cited by 875
The many ways of Wnt in cancer
Polakis, P. (2007) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2006.12.007 · Cited by 866
Novak, A., Guo, C., Yang, W., Nagy, A., & Lobe, C. G. (2000) · genesis · doi:10.1002/1526-968x(200011/12)28:3/4<147::aid-gene90>3.0.co;2-g · Cited by 844
The murine gene p27Kip1 is haplo-insufficient for tumour suppression
Fero, M. L., Randel, E., Gurley, K. E., Roberts, J. M., & Kemp, C. J. (1998) · Nature · doi:10.1038/24179 · Cited by 784
Identification of cooperating oncogenes in Eμ-myc transgenic mice by provirus tagging
van Lohuizen, M., Verbeek, S., Scheljen, B., Wientjens, E., van der Guidon, H., & Berns, A. (1991) · Cell · doi:10.1016/0092-8674(91)90382-9 · Cited by 762
Xu, X., Wagner, K.-U., Larson, D., Weaver, Z., Li, C., Ried, T., Hennighausen, L., Wynshaw-Boris, A., & Deng, C.-X. (1999) · Nature Genetics · doi:10.1038/8743 · Cited by 758
Maximizing mouse cancer models
Frese, K. K., & Tuveson, D. A. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2192 · Cited by 717
The Tumor Suppressor Gene Brca1 Is Required for Embryonic Cellular Proliferation in the Mouse
Hakem, R., de la Pompa, J. L., Sirard, C., Mo, R., Woo, M., Hakem, A., Wakeham, A., Potter, J., Reitmair, A., Billia, F., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81302-1 · Cited by 667
The mighty mouse: genetically engineered mouse models in cancer drug development
Sharpless, N. E., & DePinho, R. A. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2110 · Cited by 661
Insulators: many functions, many mechanisms
West, A. G., Gaszner, M., & Felsenfeld, G. (2002) · Genes & Development · doi:10.1101/gad.954702 · Cited by 631
Cre-lox-regulated conditional RNA interference from transgenes
Ventura, A., Meissner, A., Dillon, C. P., McManus, M., Sharp, P. A., Van Parijs, L., Jaenisch, R., & Jacks, T. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0403954101 · Cited by 625
Dinulescu, D. M., Ince, T. A., Quade, B. J., Shafer, S. A., Crowley, D., & Jacks, T. (2005) · Nature Medicine · doi:10.1038/nm1173 · Cited by 604
Mosaic Analysis with Double Markers in Mice
Zong, H., Espinosa, J. S., Su, H. H., Muzumdar, M. D., & Luo, L. (2005) · Cell · doi:10.1016/j.cell.2005.02.012 · Cited by 595
Fisher, G. H., Wellen, S. L., Klimstra, D., Lenczowski, J. M., Tichelaar, J. W., Lizak, M. J., Whitsett, J. A., Koretsky, A., & Varmus, H. E. (2001) · Genes & Development · doi:10.1101/gad.947701 · Cited by 582
Comparative biology of mouse versus human cells: modelling human cancer in mice
Rangarajan, A., & Weinberg, R. A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1235 · Cited by 567
Knudson, A. G. (1986) · Annual Review of Genetics · doi:10.1146/annurev.ge.20.120186.001311 · Cited by 559
Katoh, Y., & Katoh, M. (2009) · Current Molecular Medicine · doi:10.2174/156652409789105570 · Cited by 525
Specific-locus test shows ethylnitrosourea to be the most potent mutagen in the mouse.
Russell, W. L., Kelly, E. M., Hunsicker, P. R., Bangham, J. W., Maddux, S. C., & Phipps, E. L. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.11.5818 · Cited by 517
van Lohuizen, M., Verbeek, S., Krimpenfort, P., Domen, J., Saris, C., Radaszkiewicz, T., & Berns, A. (1989) · Cell · doi:10.1016/0092-8674(89)90589-8 · Cited by 496
Transgenic mice harboring SV40 t-antigen genes develop characteristic brain tumors
Brinster, R. L., Chen, H. Y., Messing, A., van Dyke, T., Levine, A. J., & Palmiter, R. D. (1984) · Cell · doi:10.1016/0092-8674(84)90367-2 · Cited by 483
Mammalian mutagenesis using a highly mobile somatic Sleeping Beauty transposon system
Dupuy, A. J., Akagi, K., Largaespada, D. A., Copeland, N. G., & Jenkins, N. A. (2005) · Nature · doi:10.1038/nature03691 · Cited by 482
Beard, C., Hochedlinger, K., Plath, K., Wutz, A., & Jaenisch, R. (2006) · genesis · doi:10.1002/gene.20180 · Cited by 481
Brca1 deficiency results in early embryonic lethality characterized by neuroepithelial abnormalities
Gowen, L. C., Johnson, B. L., Latour, A. M., Sulik, K. K., & Koller, B. H. (1996) · Nature Genetics · doi:10.1038/ng0296-191 · Cited by 480
Reversible Activation of c-Myc in Skin
Pelengaris, S., Littlewood, T., Khan, M., Elia, G., & Evan, G. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80350-0 · Cited by 468
Distinct Thresholds Govern Myc's Biological Output In Vivo
Murphy, D. J., Junttila, M. R., Pouyet, L., Karnezis, A., Shchors, K., Bui, D. A., Brown-Swigart, L., Johnson, L., & Evan, G. I. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.018 · Cited by 456
An Oncogenomics-Based In Vivo RNAi Screen Identifies Tumor Suppressors in Liver Cancer
Zender, L., Xue, W., Zuber, J., Semighini, C. P., Krasnitz, A., Ma, B., Zender, P., Kubicka, S., Luk, J. M., Schirmacher, P., et al. (2008) · Cell · doi:10.1016/j.cell.2008.09.061 · Cited by 428
Aszterbaum, M., Epstein, J., Oro, A., Douglas, V., LeBoit, P. E., Scott, M. P., & Epstein, E. H. (1999) · Nature Medicine · doi:10.1038/15242 · Cited by 418
An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis.
Sweet-Cordero, A., Mukherjee, S., Subramanian, A., You, H., Roix, J. J., Ladd-Acosta, C., Mesirov, J., Golub, T. R., & Jacks, T. (2005) · Nature Genetics · doi:10.1038/ng1490 · Cited by 414
Cancer gene discovery in solid tumours using transposon-based somatic mutagenesis in the mouse
Collier, L. S., Carlson, C. M., Ravimohan, S., Dupuy, A. J., & Largaespada, D. A. (2005) · Nature · doi:10.1038/nature03681 · Cited by 406
Comparative Oncogenomics Identifies NEDD9 as a Melanoma Metastasis Gene
Kim, M., Gans, J. D., Nogueira, C., Wang, A., Paik, J.-H., Feng, B., Brennan, C., Hahn, W. C., Cordon-Cardo, C., Wagner, S. N., et al. (2006) · Cell · doi:10.1016/j.cell.2006.06.008 · Cited by 392
Neonatal sunburn and melanoma in mice
Noonan, F. P., Recio, J. A., Takayama, H., Duray, P., Anver, M. R., Rush, W. L., De Fabo, E. C., & Merlino, G. (2001) · Nature · doi:10.1038/35095108 · Cited by 386
Chromosomally unstable mouse tumours have genomic alterations similar to diverse human cancers
Maser, R. S., Choudhury, B., Campbell, P. J., Feng, B., Wong, K.-K., Protopopov, A., O’Neil, J., Gutierrez, A., Ivanova, E., Perna, I., et al. (2007) · Nature · doi:10.1038/nature05886 · Cited by 377
Xu, X., Qiao, W., Linke, S. P., Cao, L., Li, W.-M., Furth, P. A., Harris, C. C., & Deng, C.-X. (2001) · Nature Genetics · doi:10.1038/90108 · Cited by 373
CHD5 Is a Tumor Suppressor at Human 1p36
Bagchi, A., Papazoglu, C., Wu, Y., Capurso, D., Brodt, M., Francis, D., Bredel, M., Vogel, H., & Mills, A. A. (2007) · Cell · doi:10.1016/j.cell.2006.11.052 · Cited by 366
The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours
Youngren, K. K., Coveney, D., Peng, X., Bhattacharya, C., Schmidt, L. S., Nickerson, M. L., Lamb, B. T., Deng, J. M., Behringer, R. R., Capel, B., et al. (2005) · Nature · doi:10.1038/nature03595 · Cited by 365
Induction of ovarian cancer by defined multiple genetic changes in a mouse model system
Orsulic, S., Li, Y., Soslow, R. A., Vitale-Cross, L. A., Gutkind, J. S., & Varmus, H. E. (2002) · Cancer Cell · doi:10.1016/s1535-6108(01)00002-2 · Cited by 358
Self-citationGene transfer into genomes of human cells by the sleeping beauty transposon system
Geurts, A. M., Yang, Y., Clark, K. J., Liu, G., Cui, Z., Dupuy, A. J., Bell, J. B., Largaespada, D. A., & Hackett, P. B. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00099-6 · Cited by 351
A Transposon-Based Genetic Screen in Mice Identifies Genes Altered in Colorectal Cancer
Starr, T. K., Allaei, R., Silverstein, K. A. T., Staggs, R. A., Sarver, A. L., Bergemann, T. L., Gupta, M., O'Sullivan, M. G., Matise, I., Dupuy, A. J., et al. (2009) · Science · doi:10.1126/science.1163040 · Cited by 346
Izsvák, Z., Ivics, Z., & Plasterk, R. H. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.2000.4047 · Cited by 331
Selective Evolution of Stromal Mesenchyme with p53 Loss in Response to Epithelial Tumorigenesis
Hill, R., Song, Y., Cardiff, R. D., & Van Dyke, T. (2005) · Cell · doi:10.1016/j.cell.2005.09.030 · Cited by 324
Safran, M., Kim, W. Y., O'Connell, F., Flippin, L., Günzler, V., Horner, J. W., DePinho, R. A., & Kaelin, W. G. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0509459103 · Cited by 305
Lallemand-Breitenbach, V., Guillemin, M.-C., Janin, A., Daniel, M.-T., Degos, L., Kogan, S. C., Michael Bishop, J., & de Thé, H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.7.1043 · Cited by 305
The role of the loxP spacer region in PI site-specific recombination
Hoess, R. H., Wierzbicki, A., & Abremski, K. (1986) · Nucleic Acids Research · doi:10.1093/nar/14.5.2287 · Cited by 303
Generation of an inducible and optimized piggyBac transposon system†
Cadiñanos, J., & Bradley, A. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkm446 · Cited by 302
Mouse models of human AML accurately predict chemotherapy response
Zuber, J., Radtke, I., Pardee, T. S., Zhao, Z., Rappaport, A. R., Luo, W., McCurrach, M. E., Yang, M.-M., Dolan, M. E., Kogan, S. C., et al. (2009) · Genes & Development · doi:10.1101/gad.1771409 · Cited by 279
Transgenic RNA interference in ES cell–derived embryos recapitulates a genetic null phenotype
Kunath, T., Gish, G., Lickert, H., Jones, N., Pawson, T., & Rossant, J. (2003) · Nature Biotechnology · doi:10.1038/nbt813 · Cited by 278
Retroviral insertional mutagenesis: past, present and future
Uren, A. G., Kool, J., Berns, A., & van Lohuizen, M. (2005) · Oncogene · doi:10.1038/sj.onc.1209043 · Cited by 271
Ruivenkamp, C. A. L., van Wezel, T., Zanon, C., Stassen, A. P. M., Vlcek, C., Csikós, T., Klous, A. M., Tripodis, N., Perrakis, A., Boerrigter, L., et al. (2002) · Nature Genetics · doi:10.1038/ng903 · Cited by 259
A Mouse to Human Search for Plasma Proteome Changes Associated with Pancreatic Tumor Development
Faca, V. M., Song, K. S., Wang, H., Zhang, Q., Krasnoselsky, A. L., Newcomb, L. F., Plentz, R. R., Gurumurthy, S., Redston, M. S., Pitteri, S. J., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050123 · Cited by 257
Combinatorial patterns of somatic gene mutations in cancer
Yeang, C.-H., McCormick, F., & Levine, A. (2008) · The FASEB Journal · doi:10.1096/fj.08-108985 · Cited by 251
Engineering chromosomal rearrangements in mice
Yu, Y., & Bradley, A. (2001) · Nature Reviews Genetics · doi:10.1038/35093564 · Cited by 244
Rao, G., Pedone, C. A., Valle, L. D., Reiss, K., Holland, E. C., & Fults, D. W. (2004) · Oncogene · doi:10.1038/sj.onc.1207818 · Cited by 232
Selten, G., Cuypers, H. T., Zijlstra, M., Melief, C., & Berns, A. (1984) · The EMBO Journal · doi:10.1002/j.1460-2075.1984.tb02281.x · Cited by 231
Metabolic transformation in cancer
Tennant, D. A., Duran, R. V., Boulahbel, H., & Gottlieb, E. (2009) · Carcinogenesis · doi:10.1093/carcin/bgp070 · Cited by 225
Pfeifer, A., Brandon, E. P., Kootstra, N., Gage, F. H., & Verma, I. M. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.201415498 · Cited by 224
Noninvasive imaging of spontaneous retinoblastoma pathway-dependent tumors in mice.
Vooijs, M., Jonkers, J., Lyons, S. K., & Berns, A. J. M. (2002) · PubMed · Cited by 217
Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function
de Vries, A., Flores, E. R., Miranda, B., Hsieh, H.-M., van Oostrom, C. T. M., Sage, J., & Jacks, T. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052713099 · Cited by 207
Keng, V. W., Villanueva, A., Chiang, D. Y., Dupuy, A. J., Ryan, B. J., Matise, I., Silverstein, K. A. T., Sarver, A., Starr, T. K., Akagi, K., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1526 · Cited by 200
Mucenski, M. L., Taylor, B. A., Ihle, J. N., Hartley, J. W., Morse, H. C., Jenkins, N. A., & Copeland, N. G. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.1.301 · Cited by 199
Proviral activation of the putative oncogene Pim-1 in MuLV induced T-cell lymphomas.
Selten, G., Cuypers, H. T., & Berns, A. (1985) · The EMBO Journal · doi:10.1002/j.1460-2075.1985.tb03852.x · Cited by 198
Rego, E. M., He, L.-Z., Warrell, R. P., Wang, Z.-G., & Pandolfi, P. P. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.180290497 · Cited by 194
DLC1 is a chromosome 8p tumor suppressor whose loss promotes hepatocellular carcinoma
Xue, W., Krasnitz, A., Lucito, R., Sordella, R., VanAelst, L., Cordon-Cardo, C., Singer, S., Kuehnel, F., Wigler, M., Powers, S., et al. (2008) · Genes & Development · doi:10.1101/gad.1672608 · Cited by 187
Sipa1 is a candidate for underlying the metastasis efficiency modifier locus Mtes1
Park, Y.-G., Zhao, X., Lesueur, F., Lowy, D. R., Lancaster, M., Pharoah, P., Qian, X., & Hunter, K. W. (2005) · Nature Genetics · doi:10.1038/ng1635 · Cited by 180
Whiteaker, J. R., Zhang, H., Zhao, L., Wang, P., Kelly-Spratt, K. S., Ivey, R. G., Piening, B. D., Feng, L.-C., Kasarda, E., Gurley, K. E., et al. (2007) · Journal of Proteome Research · doi:10.1021/pr070202v · Cited by 179
Tissue-specific and reversible RNA interference in transgenic mice
Dickins, R. A., McJunkin, K., Hernando, E., Premsrirut, P. K., Krizhanovsky, V., Burgess, D. J., Kim, S. Y., Cordon-Cardo, C., Zender, L., Hannon, G. J., et al. (2007) · Nature Genetics · doi:10.1038/ng2045 · Cited by 174
Advances in imaging mouse tumour models in vivo
Lyons, S. K. (2005) · The Journal of Pathology · doi:10.1002/path.1697 · Cited by 174
Uncoupling Dendrite Growth and Patterning: Single-Cell Knockout Analysis of NMDA Receptor 2B
Espinosa, J. S., Wheeler, D. G., Tsien, R. W., & Luo, L. (2009) · Neuron · doi:10.1016/j.neuron.2009.03.006 · Cited by 172
Dupuy, A. J., Rogers, L. M., Kim, J., Nannapaneni, K., Starr, T. K., Liu, P., Largaespada, D. A., Scheetz, T. E., Jenkins, N. A., & Copeland, N. G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1135 · Cited by 168
Wallace, H. A. C., Marques-Kranc, F., Richardson, M., Luna-Crespo, F., Sharpe, J. A., Hughes, J., Wood, W. G., Higgs, D. R., & Smith, A. J. H. (2007) · Cell · doi:10.1016/j.cell.2006.11.044 · Cited by 164
Aydinlik, H., Nguyen, T. D., Moennikes, O., Buchmann, A., & Schwarz, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204982 · Cited by 164
Cancer susceptibility in the mouse: genetics, biology and implications for human cancer
Demant, P. (2003) · Nature Reviews Genetics · doi:10.1038/nrg1157 · Cited by 162
Bric, A., Miething, C., Bialucha, C. U., Scuoppo, C., Zender, L., Krasnitz, A., Xuan, Z., Zuber, J., Wigler, M., Hicks, J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.08.015 · Cited by 161
Prostate tumor progression is mediated by a paracrine TGF-β/Wnt3a signaling axis
Li, X., Placencio, V. R., Iturregui, J. M., Uwamariya, C., Sharif‐Afshar, A., Koyama, T., Hayward, S. W., & Bhowmick, N. A. (2008) · Oncogene · doi:10.1038/onc.2008.293 · Cited by 159
Higashi, A. Y., Ikawa, T., Muramatsu, M., Economides, A. N., Niwa, A., Okuda, T., Murphy, A. J., Rojas, J., Heike, T., Nakahata, T., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0802413 · Cited by 159
Targeted DNA recombination in vivo using an adenovirus carrying the cre recombinase gene.
Wang, Y., Krushel, L. A., & Edelman, G. M. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.9.3932 · Cited by 158
Epigenetic regulation of gene structure and function with a cell-permeable Cre recombinase
Jo, D., Nashabi, A., Doxsee, C. L., Lin, Q., Unutmaz, D., Chen, J., & Ruley, H. E. (2001) · Nature Biotechnology · doi:10.1038/nbt1001-929 · Cited by 152
Toward simpler and faster genome-wide mutagenesis in mice
Wu, S., Ying, G., Wu, Q., & Capecchi, M. R. (2007) · Nature Genetics · doi:10.1038/ng2060 · Cited by 152
Tumor suppressor gene identification using retroviral insertional mutagenesis in Blm‐deficient mice
Suzuki, T., Minehata, K., Akagi, K., Jenkins, N. A., & Copeland, N. G. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601215 · Cited by 148
Tumor Angiogenesis: Cause or Consequence of Cancer?
Shchors, K., & Evan, G. I. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2053 · Cited by 132
Dietary fat influences on polyp phenotype in multiple intestinal neoplasia mice
Wasan, H. S., Novelli, M. R., Bee, J., & Bodmer, W. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.7.3308 · Cited by 128
Identification of candidate cancer-causing genes in mouse brain tumors by retroviral tagging
Swartling, F. J., Brodd, J., Eklöf, C., Ferletta, M., Hesselager, G., Tiger, C., Uhrbom, L., & Westermark, B. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0402716101 · Cited by 128
A Mouse Model for the Molecular Characterization of Brca1-Associated Ovarian Carcinoma
Xing, D., & Oršulić, S. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1495 · Cited by 127
Rao, M. K., Pham, J. W., Imam, J. S., MacLean, J. A., Murali, D., Furuta, Y., Sinha‐Hikim, A. P., & Wilkinson, M. (2006) · Genes & Development · doi:10.1101/gad1367806 · Cited by 115
Noonan, F. P., Otsuka, T., Bang, S., Anver, M. R., & Merlino, G. T. (2000) · PubMed · Cited by 113
Buchholz, F., Refaeli, Y., Trumpp, A., & Bishop, J. M. (2000) · EMBO Reports · doi:10.1093/embo-reports/kvd027 · Cited by 108
Omer, C. A., Chen, Z., Diehl, R. E., Conner, M. W., Chen, H. Y., Trumbauer, M. E., Gopal-Truter, S., Seeburger, G., Bhimnathwala, H., Abrams, M. T., et al. (2000) · PubMed · Cited by 105
MYC Is Amplified in BRCA1 -Associated Breast Cancers
Grushko, T. A., Dignam, J. J., Das, S., Blackwood, A. M., Perou, C. M., Ridderstråle, K., Anderson, K. N., Wei, M.-J., Adams, A. J., Hagos, F., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0976-03 · Cited by 103
Conditional knockdown of Fgfr2 in mice using Cre-LoxP induced RNA interference
Coumoul, X., Shukla, V., Li, C., Wang, R.-H., & Deng, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni100 · Cited by 91
Tannenbaum, A., & Silverstone, H. (1949) · PubMed · Cited by 88
Zhou, Y., Rideout, W. M., Zi, T., Bressel, A., Reddypalli, S., Rancourt, R. C., Woo, J.-K., Horner, J. W., Chin, L., Chiu, M. I., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1595 · Cited by 88
MMTV mouse models and the diagnostic values of MMTV-like sequences in human breast cancer
Taneja, P., Frazier, D. P., Kendig, R. D., Maglic, D., Sugiyama, T., Kai, F., Taneja, N. K., & Inoue, K. (2009) · Expert Review of Molecular Diagnostics · doi:10.1586/erm.09.31 · Cited by 86
Building ‘validated’ mouse models of human cancer
Hann, B. C., & Balmain, A. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00283-0 · Cited by 78
Modeling sporadic loss of heterozygosity in mice by using mosaic analysis with double markers (MADM)
Muzumdar, M. D., Luo, L., & Zong, H. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0606491104 · Cited by 76
Breuer, M., Wientjens, E., Verbeek, S. J., et al. (1991) · PubMed · Cited by 70
Imaging cancer dynamics in vivo at the tumor and cellular level with fluorescent proteins
Hoffman, R. M. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9205-z · Cited by 62
Pitteri, S. J., JeBailey, L., Faça, V. M., Thorpe, J. D., Silva, M. A., Ireton, R. C., Horton, M. B., Wang, H., Pruitt, L. C. C., Zhang, Q. H., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007916 · Cited by 60
Fly MARCM and mouse MADM: Genetic methods of labeling and manipulating single neurons
Luo, L. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.01.012 · Cited by 56
Mehasseb, M. K., Bell, S. C., & Habiba, M. A. (2009) · Reproduction · doi:10.1530/rep-09-0054 · Cited by 56
Paradoxical inhibition of c-myc-induced carcinogenesis by Bcl-2 in transgenic mice.
Coste, A. D. L., Mignon, A., Fabrè, M., Gilbert, E., Porteu, A., Dyke, T. V., Kahn, A., & Perret, C. (1999) · PubMed · Cited by 54
Hung, K. E., Faça, V. M., Song, K. S., Sarracino, D. A., Richard, L. G., Krastins, B., Forrester, S., Porter, A., Kunin, A., Mahmood, U., et al. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0153 · Cited by 49
Next-generation gene targeting in the mouse for functional genomics
Gondo, Y., Fukumura, R., Murata, T., & Makino, S. (2009) · BMB Reports · doi:10.5483/bmbrep.2009.42.6.315 · Cited by 47
SU5416 selectively impairs angiogenesis to induce prostate cancer-specific apoptosis.
Huss, W. J., Barrios, R. J., & Greenberg, N. M. (2003) · PubMed · Cited by 43
Hopping around the Tumor Genome: Transposons for Cancer Gene Discovery
Collier, L. S., & Largaespada, D. A. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-3085 · Cited by 37
Induced mitotic recombination of p53 in vivo
Wang, W., Warren, M. V., & Bradley, A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607953104 · Cited by 37
Mouse Models for Sporadic Cancer
Meuwissen, R. L. J., Jonkers, J., & Berns, A. J. M. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5146 · Cited by 32
Conditional activation of a single‐copy L1 transgene in mice by Cre
An, W., Han, J. S., Schrum, C. M., Maitra, A., Köentgen, F., & Boeke, J. D. (2008) · genesis · doi:10.1002/dvg.20407 · Cited by 30
Cancer gene discovery in mouse and man
Mattison, J., van der Weyden, L., Hubbard, T., & Adams, D. J. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.03.001 · Cited by 30
Frijhoff, A. F. W., Conti, C. J., & Senderowicz, A. M. (2004) · Molecular Carcinogenesis · doi:10.1002/mc.20013 · Cited by 23
New approaches for modelling sporadic genetic disease in the mouse
Fisher, E., Lana‐Elola, E., Watson, S. D., Vassiliou, G. S., & Tybulewicz, V. L. J. (2009) · Disease Models & Mechanisms · doi:10.1242/dmm.001644 · Cited by 21
Cross-Species Oncogenomics in Cancer Gene Identification
Peeper, D. S., & Berns, A. J. M. (2006) · Cell · doi:10.1016/j.cell.2006.06.018 · Cited by 19
Stell, A., Biserni, A., Torre, S. D., Rando, G., Ramachandran, B., Ottobrini, L., Lucignani, G., Maggi, A. C., & Ciana, P. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.02.019 · Cited by 14
Germline Modification Strategies
Grisendi, S., & Pandolfi, P. P. (2004) · Wiley eBooks · doi:10.1002/0471675067.mmc004 · Cited by 6
Uhrbom, L., & Holland, E. C. (2004) · Wiley eBooks · doi:10.1002/0471675067.mmc005 · Cited by 4
Cited by
Drost, J., & Clevers, H. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0007-6 · Cited by 1,790
Self-Assembled Targeted Nanoparticles: Evolution of Technologies and Bench to Bedside Translation
Shi, J., Xiao, Z., Kamaly, N., & Farokhzad, O. C. (2011) · Accounts of Chemical Research · doi:10.1021/ar200054n · Cited by 476
Multiple Roles of APC and its Therapeutic Implications in Colorectal Cancer
Zhang, L., & Shay, J. W. (2017) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djw332 · Cited by 449
Automated microfluidic platform for dynamic and combinatorial drug screening of tumor organoids
Schuster, B., Junkin, M., Kashaf, S. S., Romero-Calvo, I., Kirby, K., Matthews, J., Weber, C. R., Rzhetsky, A., White, K. P., & Tay, S. (2020) · Nature Communications · doi:10.1038/s41467-020-19058-4 · Cited by 424
Organoid cultures for the analysis of cancer phenotypes
Sachs, N., & Clevers, H. (2014) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2013.11.012 · Cited by 371
Metadata
- Authors
- Cheon, D.-J., & Orsulic, S.
- Venue
- Annual Review of Pathology: Mechanisms of Disease
- Publisher
- Annual Reviews
- Published
- 2011-02-28
- Volume
- 6
- Issue
- 1
- Pages
- 95-119
- ISSN
- 1553-4006 (ISSN-L)
- 1553-4014
- OpenAlex
- W2163067316
- Cited by
- 395
- References
- 137
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.